Integration of Hippo-YAP signaling with metabolism

C Ibar, KD Irvine - Developmental cell, 2020‏ - cell.com
The Hippo-Yes-associated protein (YAP) signaling network plays a central role as an
integrator of signals that control cellular proliferation and differentiation. The past several …

Gut organoids: mini-tissues in culture to study intestinal physiology and disease

M Almeqdadi, MD Mana, J Roper… - American Journal of …, 2019‏ - journals.physiology.org
In vitro, cell cultures are essential tools in the study of intestinal function and disease. For the
past few decades, monolayer cellular cultures, such as cancer cell lines or immortalized cell …

The therapeutic effect of SCFA-mediated regulation of the intestinal environment on obesity

H You, Y Tan, D Yu, S Qiu, Y Bai, J He, H Cao… - Frontiers in …, 2022‏ - frontiersin.org
Intestinal environment disorder is a potential pathological mechanism of obesity. There is
increasing evidence that disorders in the homeostasis of the intestinal environment can …

New mechanisms to prevent heart failure with preserved ejection fraction using glucagon-like peptide-1 receptor agonism (GLP-1 RA) in metabolic syndrome and in …

JE Jalil, L Gabrielli, MP Ocaranza, P MacNab… - International Journal of …, 2024‏ - mdpi.com
This review examines the impact of obesity on the pathophysiology of heart failure with
preserved ejection fraction (HFpEF) and focuses on novel mechanisms for HFpEF …

S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization

X Wang, S Chen, H **ang, X Wang, J **ao… - Biochemical …, 2022‏ - Elsevier
Vascular and immune dysfunctions are thought to be related to the pathogenesis of
inflammatory bowel disease (IBD), but behind this, the exact mechanism of mucosal …

What is an L-cell and how do we study the secretory mechanisms of the L-cell?

RE Kuhre, CF Deacon, JJ Holst… - Frontiers in …, 2021‏ - frontiersin.org
Synthetic glucagon-like peptide-1 (GLP-1) analogues are effective anti-obesity and anti-
diabetes drugs. The beneficial actions of GLP-1 go far beyond insulin secretion and …

L-cell differentiation is induced by bile acids through GPBAR1 and paracrine GLP-1 and serotonin signaling

ML Lund, G Sorrentino, KL Egerod, C Kroone… - Diabetes, 2020‏ - diabetesjournals.org
Glucagon-like peptide 1 (GLP-1) mimetics are effective drugs for treatment of type 2
diabetes, and there is consequently extensive interest in increasing endogenous GLP-1 …

Enteroendocrine dynamics–new tools reveal hormonal plasticity in the gut

J Beumer, H Gehart, H Clevers - Endocrine reviews, 2020‏ - academic.oup.com
The recent intersection of enteroendocrine cell biology with single-cell technologies and
novel in vitro model systems has generated a tremendous amount of new data. Here we …

Curcumin Compensates GLP‐1 Deficiency via the Microbiota‐Bile Acids Axis and Modulation in Functional Crosstalk between TGR5 and FXR in ob/ob Mice

F Tian, T Chen, W Xu, Y Fan, X Feng… - Molecular nutrition & …, 2023‏ - Wiley Online Library
Scope Glucagon‐like peptide‐1 (GLP‐1) deficiency occurs in obesity‐related pathologies
due to defects in the intestinal lumen. And expanding the L‐cell population has emerged as …

[HTML][HTML] Digesting the mechanobiology of the intestinal epithelium

C Pérez-González, G Ceada, M Matejčić… - Current opinion in …, 2022‏ - Elsevier
The dizzying life of the homeostatic intestinal epithelium is governed by a complex interplay
between fate, form, force and function. This interplay is beginning to be elucidated thanks to …